Gentium
Company

date founded

Financing round

General

About Company
Gentium develops and manufactures natural-based therapeutics for rare diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1993

Number of employees

Company Type

For Profit

IPO status

Private

Description

Headquartered in Villa Guardia, Italy, Gentium operates independently as a research facility and production plant for drug substance pharmaceuticals. Their mission is to discover and provide new therapies to improve the lives of patients with high unmet medical needs. Recently, Gentium was acquired by Jazz Pharmaceuticals.
Similar Companies
1000
Akari Therapeutics

Akari Therapeutics

Akari develops inflammation inhibitors for rare and orphan diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

London, UK

total rounds

5

total raised

$114.25M
Esperion

Esperion

Esperion is a pharmaceutical company that develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Ann Arbor, MI, USA

total rounds

8

total raised

$849.25M
Anacor Pharmaceutical

Anacor Pharmaceutical

Anacor Pharmaceuticals develops small-molecule therapeutics to treat fungal, bacterial, and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Palo Alto, CA, USA

total rounds

9

total raised

$443.35M
Newron Pharmaceuticals

Newron Pharmaceuticals

Newron Pharmaceuticals is developing novel therapies for diseases of the central nervous system and pain.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

20091 Bresso, Metropolitan City of Milan, Italy

total rounds

10

total raised

$129.43M
M&A Details
1

Acquired by

Jazz Pharmaceuticals

announced date

19.12.2013

Financials

Co-Investors

Activity

Recent News
0